Dendreon CEO Exits Ahead of Big Debt Payment

The desperate Dendreon (DNDN) debacle just descended into despondency with the abrupt departure of Chairman and CEO John Johnson, citing "personal reasons."

Dendreon, financially troubled seller of the Provenge prostate cancer vaccine, must repay $28 million in debt by June 15. With $170 million in the bank at the end of the first quarter, Dendreon can make the debt payment, but the company has no means to pay the $560 million in debt due in 2016. Investors have been waiting for months to hear from Dendreon about plans to deal with the strangling debt. Instead, Johnson resigns. A bad omen.

To make grave matters even worse, Dendreon's board elected lead independent director Doug Watson to be the company's next chairman. Activist healthcare investor Brad Loncar has called Watson the worst director in the country. Watson and the rest of the Dendreon board are looking for a new CEO.

Johnson became Dendreon's CEO in February 2012 promising to turn around the struggling cancer vaccine maker but Provenge sales never accelerated and the company was quickly paralyzed by the crushing debt

Dendreon shares closed Monday at $2.15 ahead of the Johnson announcement. 


Adam Feuerstein writes regularly for TheStreet. In keeping with company editorial policy, he doesn't own or short individual stocks, although he owns stock in TheStreet. He also doesn't invest in hedge funds or other private investment partnerships. Feuerstein appreciates your feedback; click here to send him an email.

More from Investing

McDonald's Criticized for Not Doing More in Wake of Sexual Harassment Claims

McDonald's Criticized for Not Doing More in Wake of Sexual Harassment Claims

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Finding Stocks Right for You: Cramer's 'Mad Money' Recap (Friday 8/25/18)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Bitcoin Today: Prices Continue to Slump Heading Into Weekend

Bitcoin Today: Prices Continue to Slump Heading Into Weekend

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain